Episealer® Knee
The only individualised implant for focal cartilage lesions in the knee
Learn more
Episealer® Talus
Personalised implant for osteochondral lesions in the ankle
Learn more
Episealer® Patellofemoral System
For patients with osteoarthritis of the patellofemoral joint
Learn more
The Episurf Process
To ensure you receive the best possible treatment for your cartilage lesion, every step in the process focuses on you.
Damage Marking Report 
These images are then used to create a virtual 3D model and visualisation of your knee joint
Episealer Products
Patient testimonials
I have absolutely no pain
I can do what I want. No elite sports, but that is not necessary. Just what I want to do as a young, 38-year-old woman. It does not have to be more than that. Read moreI live the life I want to live
I have always been exercising and running, but almost fifteen years ago, my knee problems became so severe that I could not run anymore, and other kinds of exercise caused severe pain as well. Read moreMy knee does not limit me
The pain in my knee was killing me and eventually I had to give up my job. I was always aware of the damage in my knee and at times it was so bad I just wished my leg could be cut off. Read moreI have absolutely no pain
I can do what I want. No elite sports, but that is not necessary. Just what I want to do as a young, 38-year-old woman. It does not have to be more than that. Read moreI live the life I want to live
I have always been exercising and running, but almost fifteen years ago, my knee problems became so severe that I could not run anymore, and other kinds of exercise caused severe pain as well. Read moreMy knee does not limit me
The pain in my knee was killing me and eventually I had to give up my job. I was always aware of the damage in my knee and at times it was so bad I just wished my leg could be cut off. Read moreI have absolutely no pain
I can do what I want. No elite sports, but that is not necessary. Just what I want to do as a young, 38-year-old woman. It does not have to be more than that. Read moreI live the life I want to live
I have always been exercising and running, but almost fifteen years ago, my knee problems became so severe that I could not run anymore, and other kinds of exercise caused severe pain as well. Read moreMy knee does not limit me
The pain in my knee was killing me and eventually I had to give up my job. I was always aware of the damage in my knee and at times it was so bad I just wished my leg could be cut off. Read morePress releases and financial reports
Notice convening the Extraordinary General Meeting of Episurf Medical AB (publ)
The shareholders of Episurf Medical AB (publ), reg. no. 556767-0541 ("Episurf" or the "Company"), are hereby given notice to attend the Extraordinary General Meeting to be held on Thursday, 12 November 2026, at 15:00 (CET) at Episurf's office at Karlavägen 60, SE-114 49 Stockholm, Sweden. The entrance opens at 14:30 (CET). The Board of Directors has, pursuant to Chapter 7, Section 4 a of the Swedish Companies Act (Sw. aktiebolagslagen (2005:551)) and the Company's articles…
The Board of Directors of Episurf has resolved to propose the approval of a transaction to the Extraordinary General Meeting
The Board of Directors of Episurf Medical AB (publ) (“Episurf“, or the “Company“) has taken note of a press release published by Ilija Batljan Invest AB (publ), reg. no 559053-5166 (“IBI“) on 9 October 2026, according to which IBI intends to make an offer to repurchase all bonds issued by IBI with ISIN SE0016101810 (the “Bonds“) in return for a cash payment equivalent to 100 percent of the outstanding nominal amount of the Bonds, together…
Conversion of convertibles in a nominal amount of SEK 9,279,911 to 206,220,244 Class B shares
On 1 October 2026, Episurf Medical AB (publ) (“Episurf“) issued, in relation to the closing of the acquisition of the Hudiksvall portfolio, convertibles in an aggregated nominal amount of SEK 64,780,000. Convertibles in a nominal amount of SEK 9,279,911 have, as of the date of this press release, at the request from holders of convertible debentures, been converted into 206,220,244 Class B shares in Episurf at a conversion price of SEK 0.045 per share in…